# Treatment Methods for Primary Immunodeficiencies (Severe)
Treatment of severe primary immunodeficiencies is determined by which parts of the immune system are affected and how severely. Because each type of deficiency works differently, the approach also varies per patient. Below we describe the main treatment directions.
Immunoglobulin Replacement
ProveniIncluded in official guidelines, or approved by EMA or FDA
In many severe immunodeficiencies — especially B-cell and antibody deficiencies — patients are given immunoglobulins. These are antibodies obtained from donor blood and help the body fight off infections.
These immunoglobulins can be administered in different ways:
- **Intravenously** (via an infusion in the vein): this is usually given every three to four weeks.
- **Subcutaneously** (under the skin): this can be done at home, often weekly or biweekly.
Both routes are included in official guidelines as standard treatment. Recent research confirms that new formulations (such as intravenous immunoglobulins with higher concentration) are well tolerated and effectively prevent infections.
**Side effects** are usually mild: headache, chills, slight fever, muscle pain, or local reactions at the injection site. More serious side effects are rare but can occur, such as kidney damage or thrombosis; these are closely monitored.
Antibiotic Prophylaxis
ProveniIncluded in official guidelines, or approved by EMA or FDA
For patients with certain immunodeficiencies, antibiotics are prescribed as *prevention* of infections, not only for treating them. This occurs especially in conditions with high infection risk and frequent respiratory infections.
The choice of antibiotic and its intake depends on the specific defect and infection pattern. This is always determined by the treating physician based on the patient.
**Side effects** vary per antibiotic: stomach and intestinal problems, allergy, yeast and fungal infections as a side effect of long-term use.
Stem Cell Transplantation
ProveniIncluded in official guidelines, or approved by EMA or FDA
For certain very severe primary immunodeficiencies — such as X-linked adrenoleukodystrophy, certain types of SCID (Severe Combined Immunodeficiency), or syndromic immunodeficiencies — stem cell transplantation is an established treatment. In this procedure, healthy immune cells from a donor are introduced into the patient's body, usually after intensive preparation of the patient's own bone marrow.
This can be from blood or bone marrow from a related or unrelated donor, or sometimes from umbilical cord blood.
**How it works:** the donor stem cells grow out in the patient's body and build a new, functional immune system.
**Side effects** and risks are considerable: infections during recovery, graft-versus-host disease (the donor cells damage the patient's own body), and organ damage from the preparation. This treatment requires prolonged hospitalization and intensive care.
Stem cell transplantation is only suitable for selected patients and is always performed in specialized centers.
Gene therapy
ResearchediPositive results in clinical studies, not yet standard treatment
Up to **Proven** (depending on the type of deficiency)
Gene therapy is a relatively new field in which the defective gene is repaired or replaced. For a few primary immunodeficiencies — such as certain SCID forms and Wiskott-Aldrich syndrome — gene therapy is now in clinical use.
**How it works:** often stem cells from the patient's own bone marrow are removed, the gene is repaired or supplemented in the laboratory, and the improved cells are returned to the body. This can also be done using gene editing (CRISPR-like techniques).
Recent research shows that certain patients with STAT1 gain-of-function disease have seen their immune function improve after gene editing of their stem cells.
**Side effects** are not yet fully known, because gene therapy is relatively new. Potential risks are insertional mutagenesis (genes ending up in unexpected places) and unexpected immune reactions.
Gene therapy is currently limited to recognized centers and often part of research programs or clinical follow-up studies.
Specific treatments for complications
Gastrointestinal problems
ProveniIncluded in official guidelines, or approved by EMA or FDA
In certain immunodeficiencies — particularly common variable immunodeficiency (CVID) — stomach and intestinal complaints occur. Treatment focuses on underlying causes (e.g., bacterial overgrowth or inflammation) and symptom management, and may include medications that reduce inflammation or normalize gut flora.
Lung inflammation (granulomatous infiltrations)
ProveniIncluded in official guidelines, or approved by EMA or FDA
Some patients with CVID or other deficiencies develop chronic inflammatory lung diseases (granulomatous lymphocytic interstitial lung disease). These can be treated with anti-inflammatory therapy (for example, corticosteroids) or targeted anti-inflammatory medications.
Supportive care
ProveniIncluded in official guidelines, or approved by EMA or FDA
In addition to specific immune therapies, every patient receives:
- **Vaccinations** (usually live attenuated vaccines are not given, due to infection risk; inactivated vaccines are used, although their effectiveness may be limited).
- **Infection prevention:** hygiene, contact tracing, isolation during infections.
- **Monitoring:** regular blood and immune cell counts, screenings for infections and complications.
- **Psychosocial support:** coping with chronic illness, regular follow-up appointments.
Experimental approaches
ExperimentaliOngoing in study setting, outcome still unknown
Various new strategies are underway in research:
- Advanced gene editing (CRISPR-Cas9) for more conditions.
- Artificial thymus creation (for T-cell deficiencies).
- Targeted replacement of specific missing proteins.
- Research into new antibody replacement agents with longer duration of action.
These treatments are not yet available outside research programs.
Hereditary conditions such as Papillon-Lefèvre syndrome
ProveniIncluded in official guidelines, or approved by EMA or FDA
For syndromic immunodeficiencies (such as Papillon-Lefèvre syndrome, a combination of gum abnormalities, skin problems, and immunodeficiency), antibiotic prophylaxis and supportive treatment of skin and teeth are standard. In severe cases, more aggressive treatments such as stem cell transplantation may also be considered.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._